| 000 | 01046 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515125040.0 | ||
| 264 | 0 | _c20081212 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1353-8020 | ||
| 024 | 7 |
_a10.1016/j.parkreldis.2008.04.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlandini, Fabio | |
| 245 | 0 | 0 |
_aThe 6-hydroxydopamine model: news from the past. _h[electronic resource] |
| 260 |
_bParkinsonism & related disorders _c2008 |
||
| 300 |
_aS124-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAdrenergic Agents _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aParkinson Disease _xetiology |
| 700 | 1 | _aArmentero, Marie-Therese | |
| 700 | 1 | _aMartignoni, Emilia | |
| 773 | 0 |
_tParkinsonism & related disorders _gvol. 14 Suppl 2 _gp. S124-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.parkreldis.2008.04.015 _zAvailable from publisher's website |
| 999 |
_c18078575 _d18078575 |
||